Consumer Retailing Healthcare Sector

Verastem

Market Cap: US$330.8m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

SNDL

Market Cap: US$326.8m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

Phathom Pharmaceuticals

Market Cap: US$323.2m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Clinuvel Pharmaceuticals

Market Cap: AU$495.1m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Varex Imaging

Market Cap: US$318.0m

Designs, manufactures, and sells X-ray imaging components.

Aquestive Therapeutics

Market Cap: US$315.9m

Operates as a pharmaceutical company in the United States and internationally.

Outset Medical

Market Cap: US$315.6m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

National Research

Market Cap: US$314.0m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

Corvus Pharmaceuticals

Market Cap: US$310.8m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Quantum-Si

Market Cap: US$308.3m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

Alpha Teknova

Market Cap: US$306.2m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

EBR Systems

Market Cap: AU$474.2m

Develops implantable systems for wireless tissue stimulation.

Abeona Therapeutics

Market Cap: US$304.8m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

HCW Biologics

Market Cap: US$303.1m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

Rocket Pharmaceuticals

Market Cap: US$298.4m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Compass Therapeutics

Market Cap: US$297.3m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Pacific Biosciences of California

Market Cap: US$296.4m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Heron Therapeutics

Market Cap: US$294.4m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Cidara Therapeutics

Market Cap: US$294.0m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

XOMA Royalty

Market Cap: US$291.9m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Oncology Institute

Market Cap: US$290.0m

An oncology company, provides various medical oncology services in the United States.

Entrada Therapeutics

Market Cap: US$287.0m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Terns Pharmaceuticals

Market Cap: US$286.5m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Aurora Cannabis

Market Cap: CA$391.9m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Candel Therapeutics

Market Cap: US$280.1m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Tonix Pharmaceuticals Holding

Market Cap: US$278.8m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Tvardi Therapeutics

Market Cap: US$278.5m

Operates as a biotechnology company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases.

Palvella Therapeutics

Market Cap: US$277.9m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

Animalcare Group

Market Cap: UK£205.6m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Allogene Therapeutics

Market Cap: US$277.8m

A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.

Olema Pharmaceuticals

Market Cap: US$277.1m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Monte Rosa Therapeutics

Market Cap: US$276.8m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

Tango Therapeutics

Market Cap: US$275.3m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Solid Biosciences

Market Cap: US$274.4m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Cryoport

Market Cap: US$270.7m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Silence Therapeutics

Market Cap: US$270.6m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.